Fluor Corporation is a big company that helps build things like buildings and bridges. They told everyone how much money they made in the last three months of the year, and it was more than people thought. But they also said they didn't sell as much stuff as people expected. Because of this, some people who own parts of Fluor Corporation (called shares) decided to sell their shares, which made the price of the shares go down by about 8%. This is like when you have a favorite toy and it doesn't do as well in a game as you thought it would, so you decide to trade it for another toy. There are other companies that had big changes in their share prices today too. One company called TRxADE HEALTH sold part of itself to another company for a lot of money and its shares went up by 214%. Read from source...

- The article title is misleading and sensationalized, as it suggests that Fluor shares are trading lower by around 8%, when in fact they fell by only 7.7%. This is a minor difference, but it may create confusion or panic among investors who rely on headlines for quick information.
- The article does not provide any context or explanation for why Fluor's sales were lower than expectations, nor does it mention how the company plans to address this issue in the future. It merely states that the sales came in at $3.82 billion versus expectations of $4.11 billion, without analyzing the reasons behind the discrepancy or its implications for the business.
- The article focuses on one positive aspect of Fluor's earnings report (beating earnings estimates by 11 cents per share) and one negative aspect (missing revenue estimates by $0.29 per share), without balancing them with other factors that may influence the company's performance, such as its growth prospects, market share, competitive advantages, or operational efficiency. This creates an imbalanced and incomplete picture of Fluor's situation, which may not reflect its true value or potential.
- The article does not mention any other stocks moving in Tuesday's session besides TRxADE HEALTH, Inc., which is irrelevant to the main topic of Fluor shares. This seems like an attempt to fill space and attract attention, rather than providing useful information to readers who are interested in Fluor or the broader market trends.
- The article ends abruptly with a sentence that does not connect to the previous paragraph or the title, leaving the reader wondering what happened to TRxADE HEALTH, Inc., why its shares jumped by 214%, and how it relates to Fluor's situation. This is poor writing and editing, as it suggests a lack of coherence and professionalism in the content.